Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Munitz

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Journal of Clinical Psychopharmacology|January 5, 2002
Cyproheptadine versus propranolol for the treatment of acute neuroleptic-induced akathisia: a comparative double-blind studyT Fischel, H Hermesh, D Aizenberg, et al.
International Clinical Psychopharmacology|March 14, 2002
Mianserin or placebo as adjuncts to typical antipsychotics in resistant schizophreniaR Shiloh, Z Zemishlany, D Aizenberg, et al.
Clinical Neuropharmacology|June 1, 1993
The platelet benzodiazepine receptor is unaltered in obsessive-compulsive disorderR Weizman, H Hermesh, L Karp, et al.
Psychiatry Research|July 1, 1991
TRH stimulation test in obsessive-compulsive patientsD Aizenberg, H Hermesh, I Gil-ad, et al.
Biological Psychiatry|August 1, 1996
Electroconvulsive therapy down-regulates platelet peripheral-type benzodiazepine receptors in medication-resistant major depressed patientsR Weizman, L Karp, D E Dar, et al.
The British Journal of Psychiatry : the Journal of Mental Science|October 1, 1995
Cyproheptadine treatment in neuroleptic-induced akathisiaD Weiss, D Aizenberg, H Hermesh, et al.
Journal of the Neurological Sciences|August 1, 1979
Further studies on cell-mediated immunity to myelin basic protein in schizophrenic patientsE Livni, H Munitz, S Tyano, et al.
Journal of the Neurological Sciences|December 1, 1976
Cell-mediated immunity to human myelin basic protein in schizophrenic patientsA Kuritzky, E Livni, H Munitz, et al.
American Journal of Medical Genetics|December 31, 1997
Velocardiofacial manifestations and microdeletions in schizophrenic inpatientsD Gothelf, A Frisch, H Munitz, et al.
Schizophrenia Research|February 16, 1999
Clinical characteristics of schizophrenia associated with velo-cardio-facial syndromeD Gothelf, A Frisch, H Munitz, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Journal of Clinical Psychopharmacology|January 5, 2002
Cyproheptadine versus propranolol for the treatment of acute neuroleptic-induced akathisia: a comparative double-blind studyT Fischel, H Hermesh, D Aizenberg, et al.
International Clinical Psychopharmacology|March 14, 2002
Mianserin or placebo as adjuncts to typical antipsychotics in resistant schizophreniaR Shiloh, Z Zemishlany, D Aizenberg, et al.
Clinical Neuropharmacology|June 1, 1993
The platelet benzodiazepine receptor is unaltered in obsessive-compulsive disorderR Weizman, H Hermesh, L Karp, et al.
Psychiatry Research|July 1, 1991
TRH stimulation test in obsessive-compulsive patientsD Aizenberg, H Hermesh, I Gil-ad, et al.
Biological Psychiatry|August 1, 1996
Electroconvulsive therapy down-regulates platelet peripheral-type benzodiazepine receptors in medication-resistant major depressed patientsR Weizman, L Karp, D E Dar, et al.
The British Journal of Psychiatry : the Journal of Mental Science|October 1, 1995
Cyproheptadine treatment in neuroleptic-induced akathisiaD Weiss, D Aizenberg, H Hermesh, et al.
Journal of the Neurological Sciences|August 1, 1979
Further studies on cell-mediated immunity to myelin basic protein in schizophrenic patientsE Livni, H Munitz, S Tyano, et al.
Journal of the Neurological Sciences|December 1, 1976
Cell-mediated immunity to human myelin basic protein in schizophrenic patientsA Kuritzky, E Livni, H Munitz, et al.
American Journal of Medical Genetics|December 31, 1997
Velocardiofacial manifestations and microdeletions in schizophrenic inpatientsD Gothelf, A Frisch, H Munitz, et al.
Schizophrenia Research|February 16, 1999
Clinical characteristics of schizophrenia associated with velo-cardio-facial syndromeD Gothelf, A Frisch, H Munitz, et al.
Pageof 12